These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11179485)

  • 1. Absence of p51 alteration in human ovarian cancer.
    Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
    Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene.
    Yanaihara N; Okamoto A; Matsufuji S
    Int J Oncol; 2003 Sep; 23(3):567-75. PubMed ID: 12888889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
    Hagiwara K; McMenamin MG; Miura K; Harris CC
    Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation and expression of the p51 gene in human lung cancer.
    Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
    Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
    Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
    Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of p51 mutation in human hepatocellular carcinoma.
    Hamada K; Koyama T; Shimizu K; Ikawa S; Kawate S; Yokota J; Ohwada S; Morishita Y
    Cancer Lett; 2000 Feb; 148(2):161-4. PubMed ID: 10695992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
    Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
    Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
    Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alterations in DPC4 gene in pancreatic cancers].
    Gu L; Chen J; Cui Q
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.